Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Sales | 57 | 50 | 43 | 50 | 58 |
| Cost of Goods | 2,692 | 0 | 0 | N/A | N/A |
| Gross Profit | -2,641 | 50 | 50 | 50 | 58 |
| Operating Expenses | 692 | 1,497 | 1,160 | 0 | 0 |
| Operating Income | -2,635 | -1,447 | -1,117 | 50 | 12,945 |
| Interest Expense | -137 | 0 | 0 | 0 | 0 |
| Other Income | 270 | 328 | 13 | 0 | 561 |
| Pre-tax Income | -2,228 | -1,119 | -1,104 | 50 | 13,506 |
| Net Income Continuous | -2,227 | -1,119 | -1,104 | -1,546 | 5,713 |
| Net Income | $-2,227 | $-1,119 | $-1,104 | $-1,546 | $-1,061 |
| EPS Basic Total Ops | -5,000.00 | -2,500.00 | -2,500.00 | -5,000.00 | 7,489.00 |
| EPS Basic Continuous Ops | -5,000.00 | -2,500.00 | -2,500.00 | -5,000.00 | -17,083.33 |
| EPS Diluted Total Ops | -1.00 | -0.50 | -0.50 | -1.00 | -9.50 |
| EPS Diluted Continuous Ops | -5,567.50 | -2,797.50 | -2,760.00 | -5,153.33 | -14,883.33 |
| EBITDA(a) | $-2,635 | $-1,441 | $-1,117 | $50 | $58 |